Yosuke Mitsui*†, Nahoko Tomonobu*, Masami Watanabe†, Rie Kinoshita*, I Wayan Sumardika*‡, Chen Youyi*,
Hitoshi Murata*, Ken-ichi Yamamoto*, Takuya Sadahira†, Acosta Gonzalez Herik Rodrigo*†, Hitoshi Takamatsu*,
Kota Araki*§, Akira Yamauchi¶, Masahiro Yamamura#, Hideyo Fujiwara**, Yusuke Inoue††, Junichiro Futami‡‡,
Ken Saito§§, Hidekazu Iioka§§, Eisaku Kondo§§, Masahiro Nishibori¶¶, Shinichi Toyooka§, Yasuhiko Yamamoto##,
Yasutomo Nasu†, Masakiyo Sakaguchi*
Oncology Research, Vol.27, No.8, pp. 945-956, 2019, DOI:10.3727/096504019X15555408784978
Abstract S100A11, a member of the S100 family of proteins, is actively secreted from pancreatic ductal adenocarcinoma (PDAC) cells. However, the role of the extracellular S100A11 in PDAC progression remains unclear.
In the present study, we investigated the extracellular role of S100A11 in crosstalking between PDAC cells
and surrounding fibroblasts in PDAC progression. An abundant S100A11 secreted from pancreatic cancer cells stimulated neighboring fibroblasts through receptor for advanced glycation end products (RAGE)
upon S100A11 binding and was followed by not only an enhanced cancer cell motility in vitro but also an
increased number of the PDAC-derived… More >